13
Thu, May
85 New Articles

The Lithuanian life sciences industry has skyrocketed over the last two decades – the average annual growth within the biotechnology and pharmaceutical research and production sector reached over 19%, with 90% of its output exported. in 2017 Lithuania reached 16th place in the Scientific American Worldview biotechnology rankings. Lithuania dominates many (much) larger Central and Eastern European countries and boasts the fastest growing life science industry in Europe.

On April 30, 2020, CEE Legal Matters reported that Motieka & Audzevicius had advised the founders of Lithuania's In Balance Grid on the investment of EUR 950,000 into the company by Koinvesticinis Fondas, Contrarian Ventures, and several angel investors. We spoke with Simonas Stankus, Co-Founder & CEO of In Balance Grid, to learn more about the investment round.

Our Latest Issue